CIK 0001420720
- Non-accelerated filer
- Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262797813
- Phone
- +1 302-355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-05-01 | MCKEY JOHN D JR Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.40 | $24K | 650,000 |
| 2017-05-01 | GENERAL HILL (Ret) JAMES T. Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.40 | $24K | 550,000 |
| 2017-05-01 | Chang Glenn Director | Grant or award · Stock Option (right to buy) | +60,000 | $0.40 | $24K | 550,000 |
| 2017-02-23 | DART KENNETH BRYAN 10% owner | Purchase | +1 | 1 | ||
| 2016-04-07 | Eastern Capital LTD 10% owner | Purchase | +6,500,000 | $0.62 | $4.0M | 33,744,000 |
| 2016-01-25 | Eastern Capital LTD 10% owner | Purchase | +3,500,000 | $0.62 | $2.2M | 25,460,000 |
| 2016-01-25 | Eastern Capital LTD 10% owner | Option exercise | +1,784,000 | $0.53 | $946K | 27,244,000 |
| 2016-01-25 | Eastern Capital LTD 10% owner | Option exercise · Warrant | −1,784,000 | 0 | ||
| 2015-09-04 | TERENCE RYAN E Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +100,000 | $1.72 | $172K | 300,000 |
| 2015-09-04 | FLUG SEYMOUR Director | Grant or award · Stock Option (right to buy) | +100,000 | $1.72 | $172K | 280,000 |
| 2015-09-04 | Kay Robert Executive Chairman and CEO | Grant or award · Stock Option (right to buy) | +750,000 | $1.72 | $1.3M | 4,050,000 |
| 2015-09-04 | ERWIN ROBERT L President | Grant or award · Stock Option (right to buy) | +750,000 | $1.72 | $1.3M | 3,050,000 |
| 2015-09-04 | RUSSELL PHILIP K. Director | Grant or award · Stock Option (right to buy) | +100,000 | $1.72 | $172K | 400,000 |
| 2015-09-04 | GIANNONE MARK A Chief Financial Officer | Grant or award · Stock Option (right to buy) | +150,000 | $1.72 | $258K | 300,000 |
| 2015-09-04 | MCKEY JOHN D JR Director | Grant or award · Stock Option (right to buy) | +100,000 | $1.72 | $172K | 590,000 |
| 2015-09-04 | GENERAL HILL (Ret) JAMES T. Director | Grant or award · Stock Option (right to buy) | +100,000 | $1.72 | $172K | 490,000 |
| 2015-09-04 | Elliott Arthur Y Director | Grant or award · Stock Option (right to buy) | +100,000 | $1.72 | $172K | 400,000 |
| 2015-09-04 | Chang Glenn Director | Grant or award · Stock Option (right to buy) | +100,000 | $1.72 | $172K | 490,000 |
| 2014-09-17 | DESANTIS CARL 10% owner | Sale | −55,700 | $0.76 | $42K | 5,751,143 |
| 2014-09-16 | DESANTIS CARL 10% owner | Sale | −29,880 | $0.63 | $19K | 5,806,843 |
Page 16 of 22 · 423 trades